Diceros Therapeutics
Diceros Therapeutics is a startup headquartered in Newton, United States, founded in 2022. It has raised at least $12.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Diceros Therapeutics has raised at least $12.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Diceros Therapeutics sits inside the Dawson region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Newton
Related
- Innovation profile of Newton
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Diceros Therapeutics do?
Diceros Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Diceros Therapeutics raised?
At least $12.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Diceros Therapeutics based?
Diceros Therapeutics is headquartered in Newton, United States.
When was Diceros Therapeutics founded?
Diceros Therapeutics was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.